Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease

By afschroeder • November 10, 2026

Ridker PM, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle KR, Budoff M, Böttcher M, Cavender MA, Choudhury RP, Cornel JH, Gajos G, Komuro I, Reddy Parvathareddy KMK, Pontremoli R, Saraiva JFK, Simova II, Sloan LA, López-Suárez A, Tang YD, Tokgözoğlu L, Tsabedze N, Tsioufis K, Verma S, Vrolix M, Andersen A, Baeres FMM, Ekström K, Engelmann MDM, Gerward S, Hovingh GK, Hvelplund A, Perkovic V; ZEUS Investigators. Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease. N Engl J Med. 2026 Nov 7. doi: 10.1056/NEJMoa2612126. Epub ahead of print. PMID: 43001751.

Tags: Cardiology/Epi, Harbor UCLA, Publications

Accelerated atherosclerosis in masters athletes: Only a matter of the heart?

Hsu JJ, Churchill TW. Accelerated atherosclerosis in masters athletes: Only a matter of the heart? Am J Prev Cardiol. 2026 Sep 12;31:101818. doi: 10.1016/j.ajpc.2026.101818. PMID:[...]

Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial

Madhavan MV, Schwartz A, Lindman BR, Pibarot P, Cohen DJ, Oldemeyer JB, Babaliaros V, Fearon WF, Daniels D, Chhatriwalla A, Kavinsky CJ, Shah P, Szerlip[...]

Development of a Quantitative Contrast CT-Based TAVR-Risk Score to Reliably Predict Deformation in Bicuspid Aortic Valves

Suruga K, Patel V, Jilaihawi H, Shitan H, Sheth T, Guo Y, Nagasaka T, Ng D, Chakravarty T, Cheng W, Okada Y, Gupta A, Nakamura[...]